UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000008697
Receipt number R000010223
Scientific Title Analgesic effect and plasma ropivacaine concentrations after ultrasound-guided peripheral nerve block and postoperative continuous wound infusion in patients undergoing gynecological laparotomy
Date of disclosure of the study information 2012/08/15
Last modified on 2013/10/15 20:22:50

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Analgesic effect and plasma ropivacaine concentrations after ultrasound-guided peripheral nerve block and postoperative continuous wound infusion in patients undergoing gynecological laparotomy

Acronym

Analgesic effect and plasma ropivacaine concentrations after ultrasound-guided peripheral nerve block and postoperative continuous wound infusion in patients undergoing gynecological laparotomy

Scientific Title

Analgesic effect and plasma ropivacaine concentrations after ultrasound-guided peripheral nerve block and postoperative continuous wound infusion in patients undergoing gynecological laparotomy

Scientific Title:Acronym

Analgesic effect and plasma ropivacaine concentrations after ultrasound-guided peripheral nerve block and postoperative continuous wound infusion in patients undergoing gynecological laparotomy

Region

Japan


Condition

Condition

patients scheduled for gynecological laparotomy under general anesthesia

Classification by specialty

Obstetrics and Gynecology Anesthesiology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

We investigate the analgesic effect of postoperative continious wound infusion following peripheral nerve block,and examine the safty by measuring plasma ropivacaine concentarations.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Visual analog scale (VAS) at rest and at mobilization, assessed at 3, 24,48 and 72hours after surgery

Key secondary outcomes

1.Plasma ropivacaine concentarations before and 16, 40 and 64hours after starting continuous wound infusion
2.Time to independent ambulations
3.Consumption of rescue analgesia at 24,48,72hours after surgery
4.Incidence of nausea and vomitting
5.Ocurrence of local anesthetic intoxication by ropivacaine
6.Ocurrence of adverse effects by cathters placed into the wound


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine Device,equipment Maneuver

Interventions/Control_1

Patients will receive ultrasound-guided peripheral nerve block
with 0.3mg/kg of ropivacaine diluted 60ml under general anesthesia and laparotomy will be performed.They will receive analgesia through a multi orificce
wound catheter placed below the fascia and connected to ropivacaine
infusion(12mg/kg/50hours) after surgery.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Female

Key inclusion criteria

1.female patients(American Society of Anesthesiologists physical status 1 to 3) undergoing gynecologic laparotomy at Sumitomo hospital
2.Written informed consent is provided

Key exclusion criteria

1.over ASA-PS4
2.epidural anesthesia
3.laparoscopic surgery
4.allergy in ropivacaine

Target sample size

10


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Ai Nakamoto

Organization

Sumitomo Hospital

Division name

Department of Anesthesia

Zip code


Address

5-3-20 Nakanoshima, Kita-ku, Osaka, 530-0005, Japan

TEL

06-6443-1261

Email

nakamoto-ai@sumitomo-hp.or.jp


Public contact

Name of contact person

1st name
Middle name
Last name Ai Nakamoto

Organization

Sumitomo Hospital

Division name

Department of Anesthesia

Zip code


Address

5-3-20 Nakanoshima, Kita-ku, Osaka, 530-0005, Japan

TEL

06-6443-1261

Homepage URL


Email

nakamoto-ai@sumitomo-hp.or.jp


Sponsor or person

Institute

Sumitomo Hospital Department of Anesthesia

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

一般財団法人 住友病院(大阪府)
Sumitomo Hospital (OSAKA)


Other administrative information

Date of disclosure of the study information

2012 Year 08 Month 15 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2012 Year 08 Month 13 Day

Date of IRB


Anticipated trial start date

2012 Year 08 Month 15 Day

Last follow-up date

2012 Year 11 Month 30 Day

Date of closure to data entry

2012 Year 11 Month 30 Day

Date trial data considered complete

2012 Year 11 Month 30 Day

Date analysis concluded

2013 Year 05 Month 30 Day


Other

Other related information



Management information

Registered date

2012 Year 08 Month 15 Day

Last modified on

2013 Year 10 Month 15 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000010223


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name